Flomoxef

Flomoxef is a oxacephem antibiotic that is used in the treatment of bacterial infections. It is a broad-spectrum antibiotic, meaning it is effective against a wide range of bacteria.

Mechanism of Action

Flomoxef works by inhibiting the synthesis of bacterial cell walls. It binds to penicillin-binding proteins (PBPs) located inside the bacterial cell wall, causing the inhibition of the transpeptidase enzymes, which leads to cell lysis and death.

Indications

Flomoxef is used to treat a variety of bacterial infections, including those caused by Staphylococcus aureus, Streptococcus pneumoniae, Escherichia coli, and Klebsiella pneumoniae. It is also used in the treatment of sepsis and meningitis.

Side Effects

Like all antibiotics, flomoxef can cause side effects. These may include nausea, vomiting, diarrhea, and allergic reactions. In rare cases, it can cause serious side effects such as anaphylaxis and Clostridium difficile-associated diarrhea.

Contraindications

Flomoxef is contraindicated in patients with a known allergy to cephalosporin antibiotics. It should also be used with caution in patients with renal impairment, as it is excreted by the kidneys and may accumulate in patients with reduced renal function.

Drug Interactions

Flomoxef may interact with other medications, including other antibiotics, probenecid, and warfarin. It is important to inform your healthcare provider of all medications you are taking before starting treatment with flomoxef.

Dosage and Administration

The dosage of flomoxef varies depending on the type and severity of the infection being treated. It is usually administered intravenously or intramuscularly. The typical adult dose is 1-2 grams every 6-8 hours.

See Also

• Oxacephem
• Antibiotics
• Bacterial Infections

Flomoxef Resources
Need Help Finding a Doctor? Need help finding a doctor or specialist anywhere in the world? Explore our world directory. WikiMD's DocFinder can assist you in locating millions of physicians.	Medical Knowledge Access the latest research - Most recent articles Ongoing trials.